APA (7th ed.) Citation

J, O., C, H., D, J., S, S., SJ, L., J, K., . . . SY, C. (2022). Augmentation of the RNA m6A reader signature is associated with poor survival by enhancing cell proliferation and EMT across cancer types. Experimental & molecular medicine, 54(7), 906. https://doi.org/10.1038/s12276-022-00795-z

Chicago Style (17th ed.) Citation

J, Oh, et al. "Augmentation of the RNA M6A Reader Signature Is Associated with Poor Survival by Enhancing Cell Proliferation and EMT Across Cancer Types." Experimental & Molecular Medicine 54, no. 7 (2022): 906. https://doi.org/10.1038/s12276-022-00795-z.

MLA (9th ed.) Citation

J, Oh, et al. "Augmentation of the RNA M6A Reader Signature Is Associated with Poor Survival by Enhancing Cell Proliferation and EMT Across Cancer Types." Experimental & Molecular Medicine, vol. 54, no. 7, 2022, p. 906, https://doi.org/10.1038/s12276-022-00795-z.